Letter to the editor: Comment on GLP-1-based drugs and COVID-19 treatment
Tianru Jin, Mingyao Liu
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Pharmacology2019-20 coronavirus outbreakCoronavirus InfectionsSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicinePsychologyVirologyInternal medicineInfectious disease (medical specialty)OutbreakDiseaseDiabetes Treatment and ManagementHyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes and associated disorders